Adipose Tissue as an Endocrine–Immune Organ
Adipose tissue is an active hormonal and immune organ, not a silent store: the goal is not rapid loss but a gradual, sustainable easing of the fat cells’ burden.
Adipose tissue is not a passive storage depot but a hormonally and immunologically active organ. For metabolic health, what matters is not only fat mass but also the size, distribution, and function of fat cells. Overly large fat cells can cause local oxygen deficit, inflammation, and insulin resistance — especially when high insulin levels block fat mobilization. The microbiota[G], lifestyle, and circadian rhythm[G] together determine whether adipose tissue shifts in an inflammatory or a healthy direction. Rapid weight loss is not the goal — gradual reduction of the load on fat cells is.
Adipose tissue is not a storage depot – it is a hormonal and immune organ
Understanding the function of adipose tissue requires distinguishing between an increase in fat-cell number (hyperplasia) and an increase in their size (hypertrophy). In adulthood, weight gain usually does not come from new fat cells forming, but from existing ones becoming overfilled. In overly large fat cells, oxygen deficit develops, which draws immune cells into the tissue. So-called “crown-like” structures appear, and inflammatory cytokines — including TNF-α and IL-6[G] — are released, while adiponectin, which improves insulin sensitivity[G], drops. This is one of the foundational mechanisms in modern obesity research.
The fat cell is a hormone-producing organ that releases adipokines: leptin[G] reports the state of energy stores to the brain, adiponectin improves insulin sensitivity[G], and resistin and visfatin participate in inflammatory processes. When fat cells grow too large, these ratios shift, leptin signaling becomes disturbed, and leptin resistance[G] can develop. The brain then loses sensitivity to the satiety signal arriving from adipose tissue, and appetite can rise — even though the stores are full.
Not all fat is the same – visceral, ectopic, and TOFI
Not all fat is the same. Subcutaneous fat is less dangerous than abdominal or so-called ectopic fat. When fat accumulates in the liver, the muscles, or the pancreas, lipotoxicity can develop, which directly impairs insulin function. This is why someone with normal body weight can carry metabolic disease — the so-called TOFI phenomenon (thin outside, fat inside).
The function of fat cells is also determined by insulin[G]. Chronically elevated insulin blocks lipolysis[G], inhibits hormone-sensitive lipase (HSL), and reduces the release of fatty acids. In that state, fat is not an accessible energy source, even with full stores. This is one cause of the energy-access paradox and explains why weight loss is difficult in the presence of hormonal disorders.
There is a close relationship between fat cells and the microbiota[G]. Endotoxins (LPS[G]) originating from gut bacteria can cause low-grade inflammation in adipose tissue (increased gut permeability[G] as a mechanism is documented; “leaky gut syndrome” as a diagnosis is not a validated clinical entity). In contrast, short-chain fatty acids formed from fibers can raise adiponectin levels and improve mitochondrial[G] function and insulin sensitivity[G]. Bile-acid signaling pathways also link the microbiota to adipose-tissue function: bile acids modified by gut bacteria influence metabolism and GLP-1[G] secretion via receptors (FXR in the gut wall and the liver; TGR5 in brown adipose tissue and the L-cells of the intestinal epithelium) [63].
Why isn’t removing fat enough? The set-point problem
The above best explains why purely mechanical fat removal does not solve the problem of obesity. After liposuction the hormonal environment remains unchanged, fat often reappears in other depots, and the proportion of visceral fat may even rise. The body’s energy-regulation “set-point” does not change, so the metabolic disturbance persists.
Heterogeneity is important, however. There are metabolically healthy obese people, and there are normal-weight insulin-resistant patients. Genetic adipogenesis capacity, fat distribution, and the microbiota[G] all influence how someone responds to fat accumulation. “Metabolically healthy obesity,” however, is longitudinally unstable: a large percentage of these patients develop insulin resistance, type 2 diabetes, or cardiovascular disease within 10–20 years — so this state cannot be regarded as durably safe. To assess TOFI risk, waist circumference and waist-to-hip ratio are more reliable indicators than body weight alone (see Chapter 4).
How can fat-cell function be improved? Rhythm and lifestyle
The load on fat cells can be reduced gradually. A stable meal rhythm, adequate protein and fiber intake, Zone-2[G] movement, good sleep, and microbiota[G] support together help fat cells to empty. Slow weight loss allows inflammation to subside, the balance of adipokines to improve, and insulin sensitivity[G] to return.
Clinically this requires patience. In rapid weight loss, the large amount of free fatty acids, TNF-α, and IL-6[G] released from adipose tissue can temporarily increase the load on the liver and systemic inflammation — this is one reason why slow, sustainable weight loss is biologically more favorable than dramatic calorie restriction. Adipose tissue changes slowly, but with consistent lifestyle, inflammation drops, leptin signaling improves, and energy stores become accessible.
The state of fat cells is reversible. If you reduce inflammation, improve the hormonal environment, and support the microbiota, fat-cell function normalizes — and weight loss starts to happen on its own.
Summary of the 3-day goal: to understand that adipose tissue is a hormone- and immune-active organ, that the goal is not rapid weight loss but gradual reduction of the load on fat cells, resulting in a stable, anti-inflammatory lifestyle pattern.
- Lifestyle Journal updated with meal times and the hunger scale
- 3 main meals per day at stable times
- Every meal contains a vegetable or fiber source
- At least 6,500 steps/day
- Daily fluid target of at least 1.8 liters (2×200 ml in the morning, at least 1,000 ml during the day, 2×200 ml in the evening)
- Waist circumference recorded (one of the most reliable indicators of visceral fat)
The mechanism of “diseased” adipose tissue:
- Hypertrophy (over-growth): when fat cells stretch to the limit, oxygen deficit (hypoxia) develops inside them. This leads to cell death and inflammation.
- “Crown-like” structures: immune-system macrophages surround the dying, oversized fat cells, releasing inflammatory cytokines (TNF-α, IL-6[G]) into the circulation. This causes the persistent, low-grade systemic inflammation associated with obesity.
- Adipokine disturbance: healthy adipose tissue produces adiponectin (which improves insulin sensitivity[G]). In diseased adipose tissue this drops, while leptin[G] (the satiety signal) shoots up, but the brain becomes insensitive to it (leptin[G] resistance).
Solution strategy:
- Metabolic unloading: the point is not the calorie deficit but lowering insulin. While insulin[G] is high, hormone-sensitive lipase (HSL) is blocked — that is, the fat cell’s door remains closed, and fatty acids cannot leave.
- Slow mobilization: rapid weight loss can temporarily increase the load on the liver and systemic inflammation through the free fatty acids and inflammatory cytokines (TNF-α, IL-6[G]) released from adipose tissue. Gradual, stable lifestyle change allows adipose tissue to restructure in a healthy way.
- Microbiota[G] link: LPS[G] absorbed from the gut directly worsens fat-cell insulin sensitivity[G]. Increasing fermentable fiber reduces LPS[G] load and can raise adiponectin levels — this is the point at which the diet has a direct effect on adipose-tissue inflammation.
“Adipose tissue is an active organ, not a passive storage depot. Slow change is biologically more stable. Reducing inflammation supports weight loss.”
There is no direct, home-measurable marker of adipose-tissue inflammation — but well-being, fatigue, and post-meal energy give an indirect picture. Pay attention to that today.
- Record well-being and fatigue in the Lifestyle Journal
- Note meal times
- Every meal includes a vegetable or fiber source
- 10-minute walk after meals
- Measure waist circumference in the morning on an empty stomach — record it in the Lifestyle Journal (this is one of the best home indicators of visceral fat)
- Mental task: when was I tired or sleepy after a meal? — note 2–3 specific examples; we will come back to them tomorrow
- 3 main meals, no calorie intake in between
- Avoid ultra-processed foods for 1 day
- Fixed sleep and wake times ±30 minutes
- Step count at least 6,500
- Mental task: look at yesterday’s list — in the post-meal fatigue, what was the food? (High in carbohydrates? Low in protein? A lot of processed foods?)
- Eating window no more than 12 hours
- Fluid intake: at least 1.8 l
- Break up sitting every hour with brief movement
- 10-minute walk after meals
- Mental task: when was my energy steady throughout the day? — what was different about that day’s eating compared to the previous one?
- body weight;
- meal times and contents (B–D);
- post-meal walk (Y/N);
- daily protein intake (g);
- energy density[G] (0/+/++);
- NOVA[G] level;
- sleep quality (1–5);
- hunger scale (1–5);
- step count;
- bedtime / wake time (AC, AD);
- stool Bristol (1–7);
- bloating;
- daily stool count;
- fluid intake (l);
- UltraBiome dose;
- LOT identifier;
The goal of these 3 days is to reduce the hormonal load on fat cells, ease low-grade inflammation, improve insulin sensitivity[G], and stabilize the microbiota[G].
References
[63] Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. Bile acids and the gut microbiome. Curr Opin Gastroenterol. 2014. Link
Review of the bile acid–gut microbiome axis in health and disease, focusing on two major microbial pathways for bile salt degradation and the impact of bile acid composition on microbiota and host physiology. Bile acid pool size is now recognized as a function of microbial bile acid metabolism. Bile acids regulate the microbiome at the highest taxonomic levels and act as signalling hormones, with emerging evidence implicating them in liver carcinogenesis. The review frames bile acids as bidirectional mediators of host–microbiome crosstalk.